Glucose utilization was activated by binding of AAC2 to alternative sites on the leptin receptor (LepR) and was sufficient to treat mice with T1D and T2D, and to reduce anxiety in diabetic mice [31]. Here, LEPR is linked to type 1 diabetes mellitus.